Heartflow, Inc.HTFLEarnings & Financial Report
Nasdaq · Health Care · Surgical & Medical Instruments & Apparatus
HeartFlow, Inc. develops non-invasive cardiovascular diagnostic solutions for global healthcare providers. Its core product uses CT scan data to build 3D coronary artery models, assess blood flow to detect blockages, and support clinicians in making personalized heart disease treatment decisions without invasive procedures.
Insider Transactions
Net 90d: −$63.15M · buys $0 / sells $63.15MRange:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-10 | Farquhar John C.M. | Chief Executive Officer | Sell (open market) | 22.6K | $26.72 | $602.9K |
| 2026-04-01 | Campbell Rogers | Chief Medical Officer | Option exercise | 291 | $8.33 | $2.4K |
| 2026-04-01 | Campbell Rogers | Chief Medical Officer | Option exercise | 19.1K | $2.22 | $42.4K |
| 2026-04-01 | Campbell Rogers | Chief Medical Officer | Option exercise | 40.8K | $2.22 | $90.5K |
| 2026-04-01 | Campbell Rogers | Chief Medical Officer | Option exercise | 6.8K | $2.22 | $15.2K |
| 2026-04-01 | Campbell Rogers | Chief Medical Officer | Sell (open market) | 64.5K | $24.64 | $1.59M |
| 2026-03-24 | HealthCor Partners Management LP | Director | Other | 4.62M | — | — |
| 2026-03-24 | Lightcap Jeffrey C | Director | Other | 206.3K | $0.00 | $0 |
| 2026-03-19 | Campbell Rogers | Chief Medical Officer | Option exercise | 19.4K | $2.22 | $43.1K |
| 2026-03-19 | Campbell Rogers | Chief Medical Officer | Option exercise | 47.6K | $2.22 | $105.7K |
1–10 of 28
Page 1 / 3